Drug Discovery Unit

We translate basic science into lead compounds to validate putative drug targets, to use as tools to investigate disease pathways and, when appropriate, advance to pre-clinical drug candidates.

Scientist working in lab
On this page

We work to biotech style philosophy and standards incorporating, dynamic, goal driven project management based on target product profiles and compound selection criteria. Our major research themes are: 

  • neglected tropical diseases
  • innovative targets and pathways

The DDU has all of the capabilities required for:

  • early phase drug discovery
  • assay development
  • high throughput screening
  • cell biology
  • medicinal chemistry
  • structural biology
  • computational chemistry
  • DMPK

All of these capabilities operate under one management structure to ensure an integrated approach and rapid progress.

Currently the team is about 120 people and includes substantial experience from the pharmaceutical/ biotech sector. This website contains details of current programmes and supporting infrastructure.

Visit the DDU website

Head of Unit

Executive

Leadership

Name Role Email
Dr Laura Cleghorn TB Portfolio Manager [email protected]
Dr Vincent Postis Molecular Interaction Team Leader [email protected]
Dr Gary Tarver Synthetic Methodologies Team Leader [email protected]
Dr Duncan Scott Team Leader [email protected]

Publications

View publications from the Drug Discovery Unit

Stories